Insights

Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.

Dr Salwen-Deremer discusses how the use of cognitive behavioral therapy can help relieve sleep disruption and other factors that contribute to fatigue among patients with inflammatory bowel disease.

Dr Regueiro discusses his presentation at GUILD 2023 on multidisciplinary approaches needed to manage anal strictures, peristomal complications, diversion colitis and proctitis, pouchitis and other complications of inflammatory bowel disease.

In this episode of IBD Drive Time, Dr Bharati Kochar speaks about managing IBD care among frail and older patients during the ongoing COVID-19 pandemic with hosts Dr Ray Cross and Dr Millie Long.

Dr Dulai, from Northwestern University in Chicago, discusses the use of decision support tools to help clinicians choose and maximize therapies for patients with inflammatory bowel disease rather than trying to force an individual patient's...

Dr Allegretti, from Brigham and Women's Hospital in Boston, talks with our hosts Raymond Cross, MD, and Millie Long, MD, on the risks of Clostridioides difficile among patients with inflammatory bowel disease, balancing treatment for the...

Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews the risks of cancer among patients with primary sclerosing cholangitis and inflammatory bowel disease, including bile duct cancer and hepatocellular carcinoma, and how to...

In this episode of IBD Drive Time, Dr Millie Long discusses the advances in care for children and transitioning pediatric patients to adult care with inflammatory bowel disease with Dr Jeremy Adler, a pediatric IBD specialist.

Dr Kinnucan reviews her presentation to advanced practice professionals at the Crohn's & Colitis Congress on implementing a treat to target strategy for patients with inflammatory bowel disease.